Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IVP
IVP logo

IVP Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
2.21M
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
15.39M
EV/OCF(TTM)
--
P/S(TTM)
0.01
Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals throughout the United States. The Company specializes in small animal general practice hospitals which serve all types of companion pets, emphasizing canine and feline breeds and including equine care. Services provided at its hospitals include preventive care for companion animals, consisting of annual health exams, including parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; skin and coat health and many breed specific preventive care services. Surgical offerings include all soft tissue procedures, such as spays and neuters, mass removals, splenectomies and can also include gastropexies, orthopedic procedures and other types of surgical offerings based on a doctor’s training. In many locations, additional means of care and alternative procedures are also offered, such as acupuncture, chiropractic and other health and wellness offerings.
Show More

Events Timeline

(ET)
2026-01-16
16:20:00
Inspire Veterinary Files to Sell 200M Shares of Class A Common Stock
select
2025-10-22 (ET)
2025-10-22
08:21:16
Inspire Veterinary Launches Online Pharmacy for Pets
select
2025-09-25 (ET)
2025-09-25
08:50:19
Inspire Veterinary Shares Year-to-Date Momentum Update with Shareholders
select
2025-09-02 (ET)
2025-09-02
08:57:17
Inspire Veterinary Meets Nasdaq Listing Standards Again
select
2025-09-02
08:22:38
Inspire Veterinary Restores Compliance with Nasdaq Regulations
select
2025-08-14 (ET)
2025-08-14
08:42:43
Inspire Veterinary reports Q2 EPS (50c) vs. (70c) last year
select
2025-08-07 (ET)
2025-08-07
09:03:54
Inspire Veterinary signs non-binding LOI to acquire New Jersey animal hospital
select
2025-08-04 (ET)
2025-08-04
08:44:04
Inspire Veterinary announces up to $10M in financing
select
2025-07-15 (ET)
2025-07-15
08:27:58
Inspire Veterinary launches company-wide incentive program
select
2025-06-10 (ET)
2025-06-10
08:27:02
Inspire Veterinary integrates AI platform into practice management software
select

News

Benzinga
9.5
01-15Benzinga
Goldman Sachs Reports Q4 Earnings of $14.01 Per Share, Beating Estimates
  • Goldman Sachs Earnings Highlight: The Goldman Sachs Group, Inc. (NYSE:GS) reported Q4 earnings of $14.01 per share, exceeding analyst expectations of $11.65, indicating strong profitability despite quarterly sales of $13.454 billion missing the $13.791 billion forecast, reflecting market demand fluctuations.
  • Market Performance Recovery: The Dow Jones index rose approximately 200 points, up 0.41%, while the NASDAQ surged 0.78% and the S&P 500 gained 0.55%, indicating investor optimism about market prospects, particularly following Goldman Sachs' earnings report, which may further boost market confidence.
  • Strong Tech Sector Performance: Information technology stocks gained 1.4% on Thursday, highlighting the sector's significance in the economic recovery and potentially attracting more investor attention towards the long-term growth potential of tech stocks.
  • Initial Jobless Claims Decline: U.S. initial jobless claims fell by 9,000 to 198,000, below market expectations of 215,000, demonstrating labor market resilience that could support economic growth and further enhance investor confidence in the stock market.
Benzinga
9.5
01-15Benzinga
RF Industries Reports $22.7M Q4 Sales, Shares Surge 21.4%
  • Strong Financial Performance: RF Industries reported fourth-quarter net sales of $22.7 million, a 23% increase from $18.5 million a year earlier, indicating robust market performance that is likely to boost investor confidence.
  • Significant Net Income Growth: The company achieved a non-GAAP net income of $2.1 million in Q4, translating to 20 cents per diluted share, a substantial increase from $394,000 or 4 cents per share in the same quarter last year, reflecting enhanced profitability.
  • Stock Price Surge: Following the earnings report, RF Industries' shares jumped 21.4% to $8.76 in pre-market trading, indicating strong market optimism regarding the company's future growth potential, which may attract more investor interest.
  • Quarterly Growth Trend: Compared to $19.8 million in sales for Q3 of fiscal 2025, the fourth-quarter sales increased by 15%, demonstrating the company's effective strategies in expanding market share and enhancing product demand.
Benzinga
4.5
01-14Benzinga
U.S. Retail Sales Rise 0.6% MoM, Tech Stocks Decline
  • Retail Sales Surge: U.S. retail sales increased by 0.6% month-over-month in November, marking the largest surge since July, indicating a potential rebound in consumer spending that could positively impact economic recovery.
  • Tech Stock Decline: Information technology stocks fell by 1.3% on Wednesday, reflecting market concerns over the tech sector, which may affect investor confidence and lead to capital outflows.
  • High-Risk Stock Surge: High Roller Technologies, Inc. (NYSE:ROLR) shares skyrocketed 289% to $13.64 after announcing a binding Letter of Intent with Crypto.com to launch an event-based prediction markets product in the U.S., demonstrating strong market demand for innovative offerings.
  • IPO Impact: Briacell Therapeutics Corp. (NASDAQ:BCTX) priced its $30 million public offering at $5.59 per unit, leading to a 53% drop in its stock price to $5.09, reflecting market sensitivity to financing activities.
Benzinga
9.5
01-14Benzinga
Bank of America Reports Q4 Net Income of $7.6 Billion, Exceeding Expectations
  • Earnings Highlight: Bank of America (BAC) reported a net income of $7.6 billion for Q4 FY2025, down from $6.8 billion a year ago, yet its EPS of 98 cents surpassed the analyst consensus estimate of 96 cents, indicating stable profitability amidst market fluctuations.
  • Revenue Growth: The bank's revenue net of interest expense increased by 7% year-over-year to $28.532 billion, exceeding the analyst consensus estimate of $27.944 billion, reflecting strong performance and effective cost management in a competitive landscape.
  • Market Dynamics: While U.S. stocks traded lower overall, with the Nasdaq Composite falling over 100 points, energy stocks rose by 0.9%, indicating a divergence in market performance that may present investors with opportunities to reassess their portfolios.
  • Economic Indicators: U.S. retail sales increased by 0.6% month-over-month in November, marking the largest surge since July, suggesting a rebound in consumer spending that could positively impact future economic growth.
Yahoo Finance
9.5
01-14Yahoo Finance
SEON Reports Over 80% ARR Growth in 2025, Raises $80 Million
  • Revenue Growth: SEON achieved over 80% annual recurring revenue (ARR) growth in 2025, significantly increasing its customer base as more organizations consolidated fraud and compliance operations, enhancing market competitiveness.
  • API Usage Surge: API usage grew over 250% from 2024, indicating deep customer adoption of the SEON platform, further driving the company's expansion across global financial services, retail, and gaming sectors.
  • Funding Support: In September, SEON raised $80 million in Series C funding led by Sixth Street Growth, bringing total funding to $187 million, which will support international growth, AI development, and broader product coverage.
  • Product Innovation: The AML suite launched in 2025 integrates customer screening, payment screening, transaction monitoring, and case management, resulting in manual review time reductions of up to 50%, significantly enhancing operational efficiency and compliance.
Benzinga
8.5
01-14Benzinga
Gelteq Ltd Reports 22% Bioavailability Increase in Cannabinoid Oral Gel, Shares Surge 50.1%
  • Bioavailability Improvement: Gelteq Ltd's oral gel delivery platform achieved over a 22% increase in bioavailability compared to an FDA-approved oil-based product in preclinical trials, indicating significant technological advantages that could enhance market acceptance and drive future sales growth.
  • Stock Surge: Following this positive announcement, Gelteq's shares surged 50.1% in pre-market trading to $1.25, reflecting strong investor confidence in the new technology and its market potential.
  • Enhanced Market Competitiveness: By improving product bioavailability, Gelteq not only meets the growing consumer demand but also positions itself more favorably in the competitive pharmaceutical market, potentially driving the company's long-term strategic development.
  • Increased Investor Interest: With Gelteq's technological advancements and stock price increase, market attention on its future performance has significantly risen, likely attracting more investors and partners, thereby facilitating the company's capital operations and business expansion.

Valuation Metrics

The current forward P/E ratio for Inspire Veterinary Partners Inc (IVP.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Inspire Veterinary Partners Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.00
Current PE
0.00
Overvalued PE
0.00
Undervalued PE
0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00

Financials

AI Analysis
Annual
Quarterly

Whales Holding IVP

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Inspire Veterinary Partners Inc (IVP) stock price today?

The current price of IVP is 0 USD — it has increased 0

What is Inspire Veterinary Partners Inc (IVP)'s business?

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals throughout the United States. The Company specializes in small animal general practice hospitals which serve all types of companion pets, emphasizing canine and feline breeds and including equine care. Services provided at its hospitals include preventive care for companion animals, consisting of annual health exams, including parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; skin and coat health and many breed specific preventive care services. Surgical offerings include all soft tissue procedures, such as spays and neuters, mass removals, splenectomies and can also include gastropexies, orthopedic procedures and other types of surgical offerings based on a doctor’s training. In many locations, additional means of care and alternative procedures are also offered, such as acupuncture, chiropractic and other health and wellness offerings.

What is the price predicton of IVP Stock?

Wall Street analysts forecast IVP stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IVP is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Inspire Veterinary Partners Inc (IVP)'s revenue for the last quarter?

Inspire Veterinary Partners Inc revenue for the last quarter amounts to 4.32M USD, increased 6.60

What is Inspire Veterinary Partners Inc (IVP)'s earnings per share (EPS) for the last quarter?

Inspire Veterinary Partners Inc. EPS for the last quarter amounts to -0.41 USD, decreased -95.74

How many employees does Inspire Veterinary Partners Inc (IVP). have?

Inspire Veterinary Partners Inc (IVP) has 113 emplpoyees as of March 30 2026.

What is Inspire Veterinary Partners Inc (IVP) market cap?

Today IVP has the market capitalization of 2.21M USD.